Leveraged Insurance Ends When Regulators See the Downside, Whatever the Math Says
The proposal usually arrives with a clean chart. Company dollars go into a permanent life insurance policy, the policy is pledged to a lender, and the borrowed money goes straight back into the business. Succession gets funded, the estate gets a tax-efficient death benefit, and working capital stays where it is. Underneath the chart sits a loan that runs for decades, and the chart says very little about where cash comes from if the numbers drift.
If you've ever reviewed one of these proposals and wondered whether your business would have to supply extra cash at exactly the wrong time, you've felt the unease a strong projection can't settle. That instinct deserves attention. A strategy can work on paper and still become unavailable when regulators judge its risks or sales practices unacceptable. Before committing, the useful question is who carries the cost if borrowing terms, policy performance or product availability changes, and whether that answer puts your business capital on the hook.
Why a projection that works does not mean regulators will keep accepting it
An Immediate Financing Arrangement is one common version. You pay the premium, assign the policy to a lender, and borrow back roughly what you paid to reinvest in the company or a portfolio. The appeal for an owner in Charlottetown or anywhere in the region is simple: protection and succession money without parking cash that the business needs.
The downside sits in three places projections tend to soften. Loan interest usually floats, and prime rose sharply through 2023 before the Bank of Canada began cutting in June 2024. Policy values beyond the guaranteed portion depend on the insurer's dividend or crediting decisions, which can fall. And if the loan balance outgrows what the policy's cash value supports, the lender can ask you to post outside collateral such as securities, real estate or business assets.
A fair objection: if the math holds, why would anyone pull the product? Because regulators look hardest at the bad years and at whether the buyer understood them. A plan can balance over 25 years and still break in year three if an owner has to find collateral during a rate spike. Insurers also step back on their own, for economic or reputational reasons, and a withdrawn product says nothing about the insurer's solvency.
Four questions that show whether your business cash is exposed
Separate two events that often get blurred. An insurer stopping new sales does not by itself cancel your policy or call your loan. Your exposure lives in the loan agreement, and lenders typically review terms at renewal, so collateral requirements and rates can tighten even while your policy stays fully in force. Ask for these four things:
A combined stress test. Higher borrowing costs and lower non-guaranteed values run together, showing any extra cash or collateral required by year. That's where pressure on your business shows up.
Three separate scenarios. What happens if new sales stop, if your lender changes renewal terms, or if a regulatory measure touches existing arrangements? Each has different consequences.
The actual exit terms. Contractual repayment triggers, plus the costs and tax consequences of reducing or ending the borrowing. An exit plan built on assumptions isn't a plan.
Your tax adviser's confirmation on interest. Deductibility depends on how the borrowed money is used and on Income Tax Act requirements. Pledging a policy as collateral doesn't make interest deductible.
Work through those and the larger picture comes into view: regulatory acceptance, financing continuity and investment performance are three separate risks, and a proposal can look strong on one while leaving you exposed on the others.
A persuasive return projection is one piece of a durable wealth strategy. Before signing, ask the adviser presenting it to set out in writing every circumstance under the actual agreements that could require you to add cash, post collateral or repay. A discontinued product rarely forces an unwind. The written answer tells you whether yours could, and what it would cost your business if it did.
The proposal usually arrives with a clean chart. Company dollars go into a permanent life insurance policy, the policy is pledged to a lender, and the borrowed money goes straight back into the business. Succession gets funded, the estate gets a tax-efficient death benefit, and working capital stays where it is. Underneath the chart sits a loan that runs for decades, and the chart says very little about where cash comes from if the numbers drift.
If you've ever reviewed one of these proposals and wondered whether your business would have to supply extra cash at exactly the wrong time, you've felt the unease a strong projection can't settle. That instinct deserves attention. A strategy can work on paper and still become unavailable when regulators judge its risks or sales practices unacceptable. Before committing, the useful question is who carries the cost if borrowing terms, policy performance or product availability changes, and whether that answer puts your business capital on the hook.
Why a projection that works does not mean regulators will keep accepting it
An Immediate Financing Arrangement is one common version. You pay the premium, assign the policy to a lender, and borrow back roughly what you paid to reinvest in the company or a portfolio. The appeal for an owner in Charlottetown or anywhere in the region is simple: protection and succession money without parking cash that the business needs.
The downside sits in three places projections tend to soften. Loan interest usually floats, and prime rose sharply through 2023 before the Bank of Canada began cutting in June 2024. Policy values beyond the guaranteed portion depend on the insurer's dividend or crediting decisions, which can fall. And if the loan balance outgrows what the policy's cash value supports, the lender can ask you to post outside collateral such as securities, real estate or business assets.
A fair objection: if the math holds, why would anyone pull the product? Because regulators look hardest at the bad years and at whether the buyer understood them. A plan can balance over 25 years and still break in year three if an owner has to find collateral during a rate spike. Insurers also step back on their own, for economic or reputational reasons, and a withdrawn product says nothing about the insurer's solvency.
Four questions that show whether your business cash is exposed
Separate two events that often get blurred. An insurer stopping new sales does not by itself cancel your policy or call your loan. Your exposure lives in the loan agreement, and lenders typically review terms at renewal, so collateral requirements and rates can tighten even while your policy stays fully in force. Ask for these four things:
Work through those and the larger picture comes into view: regulatory acceptance, financing continuity and investment performance are three separate risks, and a proposal can look strong on one while leaving you exposed on the others.
A persuasive return projection is one piece of a durable wealth strategy. Before signing, ask the adviser presenting it to set out in writing every circumstance under the actual agreements that could require you to add cash, post collateral or repay. A discontinued product rarely forces an unwind. The written answer tells you whether yours could, and what it would cost your business if it did.
Read Next
What 27 Rising Stars Under 40 Reveal About Canada's Next Wealth Model
The Deficit Fell $11.6 Billion. Your Mortgage Rate Didn't Get the Memo.
Banks Call It a Transfer Fee, but It Works Like an Exit Penalty
Calling Every Big House Privilege Costs You the Roadmap Behind It